4.4 Review

Promotion of cellular NAD+ anabolism:: Therapeutic potential for oxidative stress in ageing and Alzheimer's disease

期刊

NEUROTOXICITY RESEARCH
卷 13, 期 3-4, 页码 173-184

出版社

SPRINGER
DOI: 10.1007/BF03033501

关键词

NAD(+); Alzheimer's disease; inflammation; neurodegeneration; oxidative stress; DNA repair

向作者/读者索取更多资源

Oxidative imbalance is a prominent feature in Alzheimer's disease and ageing. Increased levels of reactive oxygen species (ROS) can result in disordered cellular metabolism due to lipid peroxidation, protein-cross linking, DNA damage and the depletion of nicotinamide adenine dinucleotide (NAD+). NAD+ is a ubiquitous pyridine nucleotide that plays an essential role in important biological reactions, from ATP production and secondary messenger signalling, to transcriptional regulation and DNA repair. Chronic oxidative stress may be associated with NAD+ depletion and a subsequent decrease in metabolic regulation and cell viability. Hence, therapies targeted toward maintaining intracellular NAD+ pools may prove efficacious in the protection of age-dependent cellular damage, in general, and neurodegeneration in chronic central nervous system inflammatory diseases such as Alzheimer's disease, in particular.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Physiology

Tissue-specific effects of exercise as NAD+-boosting strategy: Current knowledge and future perspectives

David Walzik, Wiebke Jonas, Niklas Joisten, Sergen Belen, Rob C. I. Wuest, Gilles Guillemin, Philipp Zimmer

Summary: Nicotinamide adenine dinucleotide (NAD(+)) is a coenzyme with various cell functions and has been found to be associated with diseases and aging. Exercise is suggested to restore NAD(+) homeostasis through metabolic adaption. This review discusses the impact of acute exercise and exercise training on NAD(+) metabolism and highlights their potential value as NAD(+)-boosting strategies.

ACTA PHYSIOLOGICA (2023)

Article Neurosciences

Impact of neuroinflammation on epigenetic transcriptional control of Sonic Hedgehog members in the central nervous system

Mariana Ribeiro Costa, Amanda Yasmin Ilario dos Santos, Tais Browne de Miranda, Rogerio Aires, Alex de Camargo Coque, Elizabeth Cristina Perez Hurtado, Maria Martha Bernardi, Vanessa Gallego Arias Pecorari, Denise Carleto Andia, Alexander Birbrair, Gilles J. Guillemin, Alexandra Latini, Rodrigo A. da Silva

Summary: Sonic Hedgehog (Shh) signaling plays a critical role in CNS development and its dysregulation leads to neurological disorders. However, the regulation of Shh signaling in the adult brain is not well understood. This study investigated the effects of DNA methylation on the transcriptional control of Shh signaling pathway members as well as its modulation by inflammation. The findings demonstrate the importance of methylation in the promoter regions of Shh pathway members in determining transcriptional patterns in the adult brain, and reveal the impact of neuroinflammation on the transcriptional control of these genes.

BRAIN RESEARCH (2023)

Review Geriatrics & Gerontology

Importance of NAD plus Anabolism in Metabolic, Cardiovascular and Neurodegenerative Disorders

Tessa Helman, Nady Braidy

Summary: The role of nicotinamide adenine dinucleotide (NAD+) in aging and its links to chronic diseases are discussed in this review. The mechanisms behind age-associated NAD+ decline are not well understood, but supplements aimed at increasing NAD+ levels are becoming popular. The clinical utility and benefits of NAD+ precursors in attenuating NAD+ decline and age-related disorders are explored.

DRUGS & AGING (2023)

Article Pharmacology & Pharmacy

Anti-inflammatory activities of Coleus forsteri (formerly Plectranthus forsteri) extracts on human macrophages and chemical characterization

Mael Nicolas, Malia Lasalo, Sharron Chow, Cyril Antheaume, Karl Huet, Edouard Hnawia, Gilles J. Guillemin, Mohammed Nour, Mariko Matsui

Summary: In this study, the anti-inflammatory potential of ethanolic (ePE) and cyclohexane (cPE) extracts from Coleus forsteri on LPS-induced human macrophages models was investigated. The results showed that ePE and cPE extracts significantly inhibited the production of IL-6 and TNF-alpha, two inflammatory cytokines, in PMA-derived THP-1 macrophages. The production of QUIN, an inflammatory marker, was also reduced under ePE and cPE treatment in activated human monocyte-derived macrophages. Additionally, seven abietane diterpenes were identified from the cPE extract of C. forsteri, and their potential contributions to the anti-inflammatory activities were discussed.

FRONTIERS IN PHARMACOLOGY (2023)

Correction Multidisciplinary Sciences

Microglia are both a source and target of extracellular cyclophilin A (vol 5, e02390, 2019)

Gurkiran Kaur Flora, Ryan S. Anderton, Bruno P. Meloni, Gilles J. Guillemin, Neville W. Knuckey, Gabriella MacDougall, Vance Matthews, Sherif Boulos

HELIYON (2023)

Editorial Material Clinical Neurology

Is neurocognitive ageing accelerated in virally suppressed people with HIV and multimorbidity?

Lucette A. Cysique, Bruce J. Brew

Review Oncology

Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials

Hemaasri-Neya Girithar, Ananda Staats Pires, Seong Beom Ahn, Gilles J. Guillemin, Laurence Gluch, Benjamin Heng

Summary: Breast cancer is the leading cause of cancer incidence and mortality in women worldwide. Metastasis is the main cause of death in breast cancer patients, as current treatment strategies are not effective in treating metastatic tumors. Immunotherapy and the kynurenine pathway (KP) have emerged as potential new approaches for breast cancer metastasis. This review discusses the mechanisms of immune suppression and cancer growth mediated by the KP, and provides an overview of studies and clinical trials targeting KP enzymes in breast cancer.

BRITISH JOURNAL OF CANCER (2023)

Retraction Endocrinology & Metabolism

撤稿声明: Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons (vol 29, 873, 2014) (Retraction of Vol 29, Pg 873, 2014)

Nady Braidy, Bruce J. Brew, Nibaldo C. Inestrosa, Roger Chung, Perminder Sachdev, Gilles J. Guillemin

METABOLIC BRAIN DISEASE (2023)

Review Clinical Neurology

The kynurenine pathway in traumatic brain injuries and concussion

Mona Dehhaghi, Benjamin Heng, Gilles J. Guillemin

Summary: Up to 10 million people per annum experience traumatic brain injury (TBI), 80-90% of which are mild. TBI can cause secondary brain injuries through mechanisms that are not yet fully understood but likely involve neurochemical changes triggered by inflammation, excitotoxicity, and reactive oxygen species. The kynurenine pathway (KP) is an important pathway that is overactivated during inflammation and its metabolites, such as QUIN, may have neurotoxic effects, suggesting a possible mechanism for secondary brain injury. Understanding the changes in KP metabolites during TBI is crucial to prevent or attenuate the severity of secondary brain injuries and develop biomarkers for TBI severity and risk of secondary brain injuries. This review aims to address the knowledge gap regarding the role of KP in TBI and highlight areas for future study.

FRONTIERS IN NEUROLOGY (2023)

Article Clinical Neurology

The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC

Lucette A. Cysique, David Jakabek, Sophia G. Bracken, Yasmin Allen-Davidian, Benjamin Heng, Sharron Chow, Mona Dehhaghi, Ananda Staats Pires, David R. Darley, Anthony Byrne, Chansavath Phetsouphanh, Anthony Kelleher, Gregory J. Dore, Gail V. Matthews, Gilles J. Guillemin, Bruce J. Brew

Summary: The study aims to determine the prevalence and natural history of post-acute COVID-19 objective cognitive impairment and function, as well as their relationship to demographic, clinical factors, post-acute sequelae of COVID-19, and biomarkers. The results showed that mild to moderate cognitive impairment occurred in 16% to 26% of patients during the 12-month study period, and at least 46.5% of patients experienced impairment. Impairment was associated with poorer work capacity and objectively tested anosmia at 2 months.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)

Review Biotechnology & Applied Microbiology

Current and emerging applications of saccharide-modified chitosan: a critical review

Hamed Kazemi Shariat Panahi, Mona Dehhaghi, Hamid Amiri, Gilles J. Guillemin, Vijai Kumar Gupta, Ahmad Rajaei, Yadong Yang, Wanxi Peng, Junting Pan, Mortaza Aghbashlo, Meisam Tabatabaei

Summary: The article introduces the importance of chitosan and its derivative chitin in biomaterials, particularly in terms of their antimicrobial, antioxidant, and anticancer activities. The article also points out some drawbacks in the structure of chitosan and discusses a modification method using lactose and galactose as main raw materials to prepare soluble branched chitosan.

BIOTECHNOLOGY ADVANCES (2023)

Article Cell Biology

Evaluation of Dimercaptosuccinic Acid-Coated Iron Nanoparticles Immunotargeted to Amyloid Beta as MRI Contrast Agents for the Diagnosis of Alzheimer's Disease

Marina Ulanova, Lucy Gloag, Andre Bongers, Chul-Kyu Kim, Hong Thien Kim Duong, Ha Na Kim, John Justin Gooding, Richard D. Tilley, Joanna Biazik, Wei Wen, Perminder S. Sachdev, Nady Braidy, Alexander E. Kalyuzhny

Summary: Nanoparticle-based magnetic contrast agents have been developed for early non-invasive diagnosis of Alzheimer's disease (AD) using magnetic resonance imaging (MRI). This study developed a biocompatible magnetic nanoparticle targeted to amyloid beta (A beta) plaques to enhance the sensitivity of T2-weighted MRI for imaging of amyloid pathology in AD. The nanoparticles showed no significant cytotoxicity and were able to bind to amyloid species. The study provides promising preliminary results for the development of a targeted non-invasive method for early AD diagnosis using contrast-enhanced MRI.
Review Pharmacology & Pharmacy

Combination Drug Therapy of Glioblastoma: Lessons from 3D In Vitro Models and the Roadmap for Future Research

Mahsa Vaezzadeh, Ehsan Kachooei, Shivani Krishnamurthy, Preeti Manandhar, Annemarie Nadort, Gilles J. Guillemin, Antonio Di Ieva, Marina Santiago, Benjamin Heng, Anna Guller

Summary: Combination drug therapy is a promising strategy to improve treatment outcomes for glioblastoma patients. However, there is a lack of clarity in drug testing using 3D in vitro models of glioblastoma. This review explores the available literature on the application of temozolomide (TMZ) in 3D in vitro models of glioblastoma, providing a roadmap for future combination treatment research.

ADVANCED THERAPEUTICS (2023)

Meeting Abstract Cell & Tissue Engineering

THREE-DIMENSIONAL CANCER MODEL IN THE LAB: A TOOL TO ADVANCE DETECTION AND THERAPY OF HIGH-GRADE BRAIN CANCER

Mahsa Vaezzadeh, Benjamin Heng, Anna Guller, Annemarie Nadort, Gilles J. Guillemin

TISSUE ENGINEERING PART A (2023)

Review Green & Sustainable Science & Technology

Biomass to biofuels using hydrothermal liquefaction: A comprehensive review

Hossein Shahbeik, Hamed Kazemi Shariat Panahi, Mona Dehhaghi, Gilles J. Guillemin, Alireza Fallahi, Homa Hosseinzadeh-Bandbafha, Hamid Amiri, Mohammad Rehan, Deepak Raikwar, Hannes Latine, Bruno Pandalone, Benyamin Khoshnevisan, Christian Sonne, Luigi Vaccaro, Abdul-Sattar Nizami, Vijai Kumar Gupta, Su Shiung Lam, Junting Pan, Rafael Luque, Bert Sels, Wanxi Peng, Meisam Tabatabaei, Mortaza Aghbashlo

Summary: This review explores the production of biocrude oil from biomass feedstocks through the process of hydrothermal liquefaction (HTL). It discusses the impact of process parameters on the quality, quantity, cost, and environmental impacts of biofuels. The review also highlights the challenges and prospects for the future development of biocrude oil.

RENEWABLE & SUSTAINABLE ENERGY REVIEWS (2024)

暂无数据